StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$4.92−0.45 (-8.38%)

Close on Nov 20, 2026Market cap $7.96MP/E –Yield –

Kazia Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -A$13.28M. The highest annual figure on record is -A$6.71M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Jun 30, 2025-A$13.28M–
FY2024Jun 30, 2024-A$9.58M–
FY2023Jun 30, 2023-A$15.16M–
FY2022Jun 30, 2022-A$22.76M–
FY2021Jun 30, 2021-A$9.11M–
FY2020Jun 30, 2020-A$8.81M–
FY2019Jun 30, 2019-A$6.71M–
FY2018Jun 30, 2018-A$8.66M–
FY2017Jun 30, 2017-A$11.44M–
FY2016Jun 30, 2016-A$11.98M–

More Kazia Therapeutics figures

See a number that looks wrong?